Details for Patent: 10,117,836

Which drugs does patent 10,117,836 protect, and when does it expire?

Patent 10,117,836 protects QULIPTA and UBRELVY and is included in two NDAs.

This patent has thirty-five patent family members in thirteen countries.

Summary for Patent: 10,117,836

Title:	Tablet formulation for CGRP active compounds
Abstract:	The present invention is directed to compositions comprising an extrudate or solid solution of a compound, or a salt thereof, of Formula I (API): Formula I, wherein "R.sup.a" is independently H or --F, in a water-soluble polymer matrix which further comprises a disintegration system allowing a tablet made therefrom to rapidly disintegrate in the environment in which the API is to be released. ##STR00001##
Inventor(s):	Johnson; Mary Ann (West Point, PA), Allain; Leonardo Resende (Lansdale, PA), Eickhoff; W. Mark (Lansdale, PA), Ikeda; Craig B. (Harleysville, PA), Brown; Chad D. (Quakertown, PA), Flanagan, Jr.; Francis J. (North Wales, PA), Nofsinger; Rebecca (Lansdale, PA), Marota; Melanie (Lansdale, PA), Lupton; Lisa (South San Francisco, CA), Patel; Paresh B. (Langhorne, PA), Xi; Hanmi (Furlong, PA), Xu; Wei (North Wales, PA)
Assignee:	Merck Sharp & Dohme Corp. (Rahway, NJ)
Application Number:	15/115,026
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,117,836
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Device; Dosage form;

Drugs Protected by US Patent 10,117,836

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Abbvie	QULIPTA	atogepant	TABLET;ORAL	215206-001	Sep 28, 2021		RX	Yes	No			Y
Abbvie	QULIPTA	atogepant	TABLET;ORAL	215206-002	Sep 28, 2021		RX	Yes	No			Y
Abbvie	QULIPTA	atogepant	TABLET;ORAL	215206-003	Sep 28, 2021		RX	Yes	Yes			Y
Abbvie	UBRELVY	ubrogepant	TABLET;ORAL	211765-001	Dec 23, 2019		RX	Yes	No			Y
Abbvie	UBRELVY	ubrogepant	TABLET;ORAL	211765-002	Dec 23, 2019		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 10,117,836

PCT Information
PCT Filed	January 30, 2015	PCT Application Number:	PCT/US2015/013672
PCT Publication Date:	August 13, 2015	PCT Publication Number:	WO2015/119848

International Family Members for US Patent 10,117,836

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015214502
Australia	2019226239
Australia	2021245229
Australia	2023258317
Brazil	112016017999